...
首页> 外文期刊>Cancer Cell International >MiR-144-3p promotes the tumor growth and metastasis of papillary thyroid carcinoma by targeting paired box gene 8
【24h】

MiR-144-3p promotes the tumor growth and metastasis of papillary thyroid carcinoma by targeting paired box gene 8

机译:MiR-144-3p通过靶向配对盒基因8促进甲状腺乳头状癌的生长和转移

获取原文
           

摘要

Paired box gene 8 (PAX8) is expressed in and indispensable to thyroid development. MiR-144-3p is found dys-regulated in cancers, and it can block the expression of target gens. This study sought to understand the effect of MiR-144-3p in papillary thyroid carcinoma (PTC) as well as the associated mechanisms. Real-time PCR, immunohistochemical and Western blot assays were performed to examine the expression of target miRNA and/or genes. CCK-8 and flow cytometry analysis was used to respectively test cell growth, cell cycle progression and apoptosis. Luciferase reporter assay was performed to find out whether miR-144-3p could bind to the 3′ untranslated region of PAX8 or not. We found that PAX8 decreased in PTC, while miR-144-3p increased in PTC. Over-expression of miR-144-3p promoted the cell viability and cell cycle progression. The expressions of cell-cycle-related genes, cyclin D1, cyclin-dependent kinase 2 and CDC25A were modulated by miR-144-3p. Meanwhile, the presence or absence of miR-144-3p both affected epithelial-mesenchymal transition of PTC by regulating the expression of E-cadherin, N-cadherin and vimentin. Moreover, PAX8 may be a potential direct target of miR-144-3p. Mechanically, the activation of extracellular signal–regulated kinases 1/2, Akt and c-Jun N-terminal kinases may be associated with the tumor-promoting effect of miR-144-3p. In addition, the blockage of miR-144-3p forced the anti-tumor effect delivered by X-ray exposure or paclitaxel. MiR-144-3p promoted the growth of tumor and the metastasis of PTC by targeting PAX 8. The study provided promising prognosis markers and valuable treatment strategy for PTC.
机译:配对盒基因8(PAX8)在甲状腺发育中表达且必不可少。在癌症中发现MiR-144-3p失调,它可以阻断靶基因的表达。这项研究试图了解MiR-144-3p在甲状腺乳头状癌(PTC)中的作用及其相关机制。进行实时PCR,免疫组织化学和蛋白质印迹测定以检查靶标miRNA和/或基因的表达。使用CCK-8和流式细胞仪分析分别测试细胞生长,细胞周期进程和凋亡。进行荧光素酶报告基因分析以发现miR-144-3p是否可以结合PAX8的3'非翻译区。我们发现PTC中PAX8减少,而PTC中miR-144-3p增加。 miR-144-3p的过表达促进细胞活力和细胞周期进程。 miR-144-3p调节细胞周期相关基因,细胞周期蛋白D1,细胞周期蛋白依赖性激酶2和CDC25A的表达。同时,miR-144-3p的存在与否均通过调节E-cadherin,N-cadherin和波形蛋白的表达而影响PTC的上皮-间质转化。此外,PAX8可能是miR-144-3p的潜在直接靶标。从机械上讲,细胞外信号调节激酶1/2,Akt和c-Jun N末端激酶的激活可能与miR-144-3p的促肿瘤作用有关。此外,miR-144-3p的阻滞迫使X射线暴露或紫杉醇具有抗肿瘤作用。 MiR-144-3p通过靶向PAX 8促进肿瘤的生长和PTC的转移。该研究为PTC提供了有希望的预后标志和有价值的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号